Biodegradable nanoparticles for drug and gene delivery to cells and tissue

被引:1980
作者
Panyam, J
Labhasetwar, V
机构
[1] Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Nebraska Med Ctr 986025, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA
关键词
nanotechnology; sustained release; biodegradable polymers; protein delivery; gene therapy;
D O I
10.1016/S0169-409X(02)00228-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Biodegradable nanoparticles formulated from poly (S,L-lactide-co-glycolide) (PLGA) have been extensively investigated for sustained and targeted/localized delivery of different agents including plasmid DNA, proteins and peptides and low molecular weight compounds. Research about the mechanism of intracellular uptake of nanoparticles, their trafficking and sorting into different intracellular compartments, and the mechanism of enhanced therapeutic efficacy of nanoparticleencapsulated agent at cellular level is more recent and is the primary focus of the review. Recent studies in our laboratory demonstrated rapid escape of PLGA nanoparticles from the endo-lysosomal compartment into cytosol following their uptake. Based on the above mechanism, various potential applications of nanoparticles for delivery of therapeutic agents to the cells and tissue are discussed. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:329 / 347
页数:19
相关论文
共 144 条
  • [71] Delayed re-endothelialization and T-cell infiltration following intracoronary radiation therapy in the porcine model
    Kollum, M
    Cottin, Y
    Chan, RC
    Kim, HS
    Bhargava, B
    Vodovotz, Y
    Waksman, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (02): : 495 - 501
  • [72] In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia
    Kornowski, R
    Hong, MK
    Tio, FO
    Bramwell, O
    Wu, HS
    Leon, MB
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (01) : 224 - 230
  • [73] ENHANCED MIGRATORY ACTIVITY OF VASCULAR SMOOTH-MUSCLE CELLS WITH HIGH EXPRESSION OF PLATELET-DERIVED GROWTH FACTOR-A AND FACTOR-B
    KOSTER, R
    WINDSTETTER, U
    UBERFUHR, P
    BAUMANN, G
    NIKOL, S
    HOFLING, B
    [J]. ANGIOLOGY, 1995, 46 (02) : 99 - 106
  • [74] INVITRO STUDIES OF POLY(METHYL METHACRYLATE) ADJUVANTS
    KREUTER, J
    SPEISER, PP
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (11) : 1624 - 1627
  • [75] Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: A comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers
    Kroll, RA
    Pagel, MA
    Muldoon, LL
    Roman-Goldstein, S
    Fiamengo, SA
    Neuwelt, EA
    [J]. NEUROSURGERY, 1998, 43 (04) : 879 - 886
  • [76] A DNA controlled-release coating for gene transfer: Transfection in skeletal and cardiac muscle
    Labhasetwar, V
    Bonadio, J
    Goldstein, S
    Chen, WL
    Levy, RJ
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (11) : 1347 - 1350
  • [77] Gene transfection using biodegradable nanospheres: results in tissue culture and a rat osteotomy model
    Labhasetwar, V
    Bonadio, J
    Goldstein, SA
    Levy, JR
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) : 281 - 290
  • [78] Nanoparticle drug delivery system for restenosis
    Labhasetwar, V
    Song, CX
    Levy, RJ
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1997, 24 (01) : 63 - 85
  • [79] Arterial uptake of biodegradable nanoparticles: Effect of surface modifications
    Labhasetwar, V
    Song, CX
    Humphrey, W
    Shebuski, R
    Levy, RJ
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (10) : 1229 - 1234
  • [80] Labhasetwar V., 1997, PHARM NEWS, V4, P28